FNDC5 and myocardial infarction: Collectively, these in vivo studies provide clear evidence that multiple intravenous deliveries of irisin‐treated ADSCs promote post‐MI/R cardiac repair via antiapoptotic, proangiogenic, and antifibrotic mechanisms.